CircOMA1 promotes tumour growth and metastasis of bladder cancer by modulating IGF‐IR/MAPK/EMT pathway
Open Access
- 21 August 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (8) , e983
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathwayOncology Reports, 2020
- Comprehensive circular RNA profiling reveals the regulatory role of circ_100242/miR-145 pathway in bladder cancerOncology Letters, 2020
- Circular RNA, a novel marker for cancer determination (Review)International Journal of Molecular Medicine, 2018
- FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaClinical Cancer Research, 2017
- IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insightsMolecular Cancer, 2017
- Circular RNA: A new star of noncoding RNAsCancer Letters, 2015
- Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosisCell Research, 2015
- MicroRNA‐145 directly targets the insulin‐like growth factor receptor I in human bladder cancer cellsFEBS Letters, 2014
- Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancerAnnals of Oncology, 2006
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyJournal of Clinical Oncology, 2000